Exelixis Inc. Stock
Price
Target price
€20.89
€20.89
0.340%
0.07
0.340%
€26.01
16.07.24 / Tradegate
WKN: 936718 / Symbol: EXEL / Name: Exelixis / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Exelixis Inc. Stock
Exelixis Inc. gained 0.340% compared to yesterday.
Exelixis Inc. is currently one of the favorites of our community with 20 Buy predictions and no Sell predictions.
As a result the target price of 26 € shows a positive potential of 24.46% compared to the current price of 20.89 € for Exelixis Inc..
Pros and Cons of Exelixis Inc. in the next few years
Pros
?
B****
?
M***** P*******
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Exelixis Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Exelixis Inc. | 0.340% | 1.655% | 3.982% | 17.989% | -4.525% | 44.768% | 6.920% |
Ironwood Pharmaceuticals | -3.250% | 0.000% | 6.250% | -37.696% | -41.667% | -46.396% | - |
Arrowhead Pharmaceuticals Inc. | 0.550% | 0.892% | 9.053% | -19.766% | -7.599% | -54.889% | -2.910% |
Novocure Ltd | -1.560% | 2.547% | -5.266% | -51.644% | 18.459% | -89.484% | - |
Comments
Exelixis, Inc. (NASDAQ: EXEL) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for EXEL provided by MarketBeat
Exelixis, Inc. (NASDAQ: EXEL) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for EXEL provided by MarketBeat
Exelixis, Inc. (NASDAQ: EXEL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
Show more
Ratings data for EXEL provided by MarketBeat
News
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
Many billionaire investors are going all in on artificial intelligence (AI). That's understandable. AI is quickly being integrated into businesses' day-to-day operations. The leaders in the field
Exelixis (EXEL) Q1 2024 Earnings Call Transcript
2 Stocks Under $30 to Buy and Hold
What is a reasonable sum of money to start investing in stocks? $10,000? $1,000? $500? The truth is, thanks to online brokers who now offer trades at low or no fees and fractional shares, investors